Hurley Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.8K Hold
47
– – 0.01% 280
2026
Q2
$16.9K Hold
47
– – 0.01% 287
2026
Q1
$16.7K Sell
47
-104
-69% -$37.1K 0.01% 287
2025
Q4
$49.4K Buy
151
+101
+202% +$32K 0.03% 174
2025
Q3
$14K Buy
50
+5
+11% +$1.45K 0.01% 324
2025
Q2
$12.7K Hold
45
– – 0.01% 282
2025
Q1
$14K Hold
45
– – 0.01% 296
2024
Q4
$12.7K Buy
+45
New +$13.4K 0.01% 261

Other funds holding AMGN

Hurley Capital's AMGN Position: Q3 2026 in Review

Hurley Capital held its Amgen (AMGN) position steady in Q3 2026 at 47 shares worth $19.8K. The position accounts for 0.01% of the portfolio, ranked #280.

Hurley Capital first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $49.4K in Q4 2025. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Hurley Capital held 47 shares of Amgen worth $19.8K as of Q3 2026.
  • Hurley Capital left its Amgen share count unchanged in Q3 2026.
  • Amgen made up 0.01% of Hurley Capital's portfolio in Q3 2026, its #280 holding.
  • Hurley Capital first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Hurley Capital's Amgen position peaked at $49.4K in Q4 2025.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.